The volatile anesthetic sevoflurane is
degra
de
d to fluoromethyl-2,2-
difluoro-1-(trifluoromethyl)vinyl ether (FDVE) in anesthesia machines. FDVE is nephrotoxic in rats. FDVEun
dergoes glutathione conjugation, subsequent conversion to cysteine an
d mercapturic aci
dconjugates, an
d cysteine conjugate metabolism by renal
ddle">-lyase, which is a bioactivationpathway me
diating nephrotoxicity in rats. Recent in vitro stu
dies reveale
d cytochrome P4503A-catalyze
d formation of novel sulfoxi
de metabolites of FDVE cysteine-S an
d mercapturic aci
dconjugates in rat liver an
d ki
dney microsomes. FDVE-mercapturic aci
d sulfoxi
des were moretoxic than other FDVE conjugates to renal proximal tubular cells in culture. Nevertheless,the occurrence an
d toxicological significance of FDVE sulfoxi
des formation in vivo remainunknown. This investigation
determine
d, in rats in vivo, the existence, role of P4503A, an
dnephrotoxic consequence of FDVE conjugates sulfoxi
dation. Rats were pretreate
d with
dexamethasone, phenobarbital, trolean
domycin, or nothing (controls) before FDVE, an
d then,nephrotoxicity, FDVE-mercapturate sulfoxi
de urinary excretion, an
d FDVE-mercapturatesulfoxi
dation by liver microsomes were assesse
d. The formation of FDVE-mercapturic aci
dsulfoxi
de metabolites in vivo an
d their urinary excretion were unambiguously establishe
d bymass spectrometry. Dexamethasone an
d phenobarbital increase
d, an
d trolean
domycin
decrease
d (i) liver microsomal FDVE-mercapturic aci
d sulfoxi
dation in vitro, (ii) FDVE-mercapturic aci
d sulfoxi
de urinary excretion in vivo, an
d (iii) FDVE nephrotoxicity in vivoassesse
d by renal histology, bloo
d urea nitrogen concentrations, an
d urine volume an
d proteinexcretion. Urine 3,3,3-trifluoro-2-(fluoromethoxy)propanoic aci
d, reflecting
ddle">-lyase-
depen
dentFDVE-cysteine S-conjugates metabolism, was minimally affecte
d by the pretreatments. Theseresults
demonstrate that FDVE S-conjugates un
dergo P4503A-catalyze
d sulfoxi
dation in ratsin vivo, an
d this sulfoxi
dation pathway contributes to nephrotoxicity. FDVE S-conjugatessulfoxi
dation constitutes a newly
discovere
d mechanism of FDVE bioactivation an
d toxicificationin rats, in a
ddition to
ddle">-lyase-catalyze
d metabolism of FDVE-cysteine S-conjugates.